Keith Meister, an activist investor, joins Illumina's board, following pushes for company changes.

Keith Meister, an activist investor, is set to join the board of Illumina, a leading gene sequencing company. This move follows Meister's efforts to push for changes at the company. The Wall Street Journal first reported the news.